GlassScriptPhysician profile
Timothy Dekker
NPI 1538516646
$7,017.38
in general payments reported to CMS, 2019-2025
7 companies · $1,162 in 2025
The $1,162 reported for 2025 was more than what 91% of Sports Medicine (Family Medicine) providers received nationally (typical 2025 total: $113).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,200 · 2022: $2,388 · 2023: $1,858 · 2024: $409 · 2025: $1,162.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,615 · Food and Beverage: $814.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,614.50 |
| Food and Beverage | $814.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $3,035.00 | 2021-2025 | |
| Pacira Pharmaceuticals Incorporated | $2,351.66 | 2022 | |
| Arthrex, INC. | $1,532.41 | 2023-2025 | |
| Convatec INC. | $29.22 | 2023 | |
| Aroa Biosurgery Incorporated | $27.52 | 2023 | |
| Stimwave Technologies Incorporated | $24.85 | 2022 | |
| Gilead Sciences, INC. | $16.72 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Dekker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.